Armata Pharmaceuticals - Crunchbase Company Profile & Funding

Q: Who invested in Armata Pharmaceuticals?

Armata Pharmaceuticals has 8 investors including U.S. Department of Defense And Innoviva.

Q: How much funding has Armata Pharmaceuticals raised to date?

Armata Pharmaceuticals has raised obfuscated.

Overview

Armata Pharmaceuticals

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Armata Pharmaceuticals

CB Rank

18755

Armata Pharmaceuticals is a biotechnology company developing novel products to diagnose, treat and prevent human and animal diseases.

Founded

obfuscation

Public

Grant

Marina Del Rey, California, United States

51-100

www.armatapharma.com/

Biotechnology

Health Care

Health Diagnostics

Personal Health

Therapeutics

Funding Rounds

Grant

OBF

obfuscation

Post-IPO Debt

OBF

obfuscation

Grant

OBF

obfuscation

Key People

Steve Martin: Chief Financial Officer
Past Role: AmpliPhi Biosciences, SVP & Chief Financial Officer
Maxwell Anderson: Co-Founder

Details

Sub-Organization of

Armata Pharmaceuticals

Legal Name

Armata Pharmaceuticals Inc.

Also Known As

C3J Therapeutics

Operating Status

Active

Stock Symbol

NYSEMKT:ARMP

Company Type

For Profit

Founders

Maxwell Anderson, Wenyuan Shi, Wenyuan Shi

About the Company

Armata Pharmaceuticals is a clinical-stage biotechnology company focused on the development of precisely targeted bacteriophage therapeutics for the treatment of drug-resistant bacterial infections.

Antibiotic overuse has led to the marked rise of multidrug-resistant bacteria, putting us on the verge of a post-antibiotic era in which common

infections can be serious or life-threatening. Additionally, the use of broad-spectrum antibiotics is known for disrupting the ecology of the human microbiome, leading to disease.

The company was founded in 2005 and is based in Marina del Rey, CA, USA.

Phone Number

+1 310 665 2928

Contact Email

info@armatapharma.com

Predictions & Insights

Growth Insight

See this Growth Insight

Armata Pharmaceuticals is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Products & Services

AP-PA02

AP-PA02 is a phage cocktail targeting Pseudomonas aeruginosa for treating respiratory infections, particularly in cystic fibrosis and non-cystic fibrosis bronchiectasis patients.

AP-PA02 & AP-PA03

Phage therapeutics targeting Pseudomonas aeruginosa infections, designed to treat antibiotic-resistant bacterial infections.

Research & Development

Armata Pharmaceuticals is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Grant - Armata Pharmaceuticals	1	obfuscated obfuscation	U.S. Department of Defense	Grant
obfuscated obfuscation	Grant - Armata Pharmaceuticals	1	obfuscated obfuscation	U.S. Department of Defense	Grant
obfuscated obfuscation	Grant - Armata Pharmaceuticals	1	obfuscated obfuscation	U.S. Department of Defense	Grant
obfuscated obfuscation	Grant - Armata Pharmaceuticals	1	obfuscated obfuscation	U.S. Department of Defense	Grant
obfuscated obfuscation	Grant - Armata Pharmaceuticals	1	obfuscated obfuscation	U.S. Department of Defense	Grant

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Grant - Armata Pharmaceuticals	1	obfuscated obfuscation	U.S. Department of Defense	Grant
obfuscated obfuscation	Grant - Armata Pharmaceuticals	1	obfuscated obfuscation	U.S. Department of Defense	Grant
obfuscated obfuscation	Grant - Armata Pharmaceuticals	1	obfuscated obfuscation	U.S. Department of Defense	Grant
obfuscated obfuscation	Grant - Armata Pharmaceuticals	1	obfuscated obfuscation	U.S. Department of Defense	Grant
obfuscated obfuscation	Grant - Armata Pharmaceuticals	1	obfuscated obfuscation	U.S. Department of Defense	Grant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
U.S. Department of Defense	Yes	Grant - Armata Pharmaceuticals	—
U.S. Department of Defense	Yes	Grant - Armata Pharmaceuticals	—
U.S. Department of Defense	Yes	Grant - Armata Pharmaceuticals	—
U.S. Department of Defense	Yes	Grant - Armata Pharmaceuticals	—
U.S. Department of Defense	Yes	Grant - Armata Pharmaceuticals	—